What Are Nootropic Peptides?

What Are Nootropic Peptides?

Nootropic peptides are peptides marketed to enhance cognitive function, including memory, focus, learning, and mental clarity. The term “nootropic” comes from Greek words meaning “mind-turning.”

Common Nootropic Peptides

Peptide	Origin	Claimed Effects
Semax	Synthetic ACTH fragment	Memory, focus, neuroprotection
Selank	Synthetic tuftsin analog	Anxiety, cognition, mood
Dihexa	Synthetic small peptide	Memory, neuroplasticity
P21	CNTF-derived peptide	Neurogenesis, memory
Cerebrolysin	Porcine brain extract	Stroke recovery, dementia

How Are They Claimed to Work?

Semax

• Modulates BDNF (brain-derived neurotrophic factor)
• May affect dopamine and serotonin systems
• Proposed neuroprotective effects

Selank

• Affects GABA system (calming)
• May modulate immune function
• Claimed anxiolytic (anti-anxiety) effects

Dihexa

• Proposed to enhance hepatocyte growth factor (HGF) signaling
• May promote synapse formation
• Claimed to be extremely potent (animal data only)

What Does the Evidence Show?

Evidence by Peptide

Peptide	Human Studies	FDA Status
Semax	Some (mostly Russian)	Not FDA approved
Selank	Some (mostly Russian)	Not FDA approved
Dihexa	None published	Not approved
P21	None published	Not approved
Cerebrolysin	Yes (limited)	Not FDA approved

Important Context

• Semax and Selank are approved in Russia for specific medical conditions but not in the US or EU
• Most human studies come from Russian researchers and may not meet Western clinical trial standards
• Dihexa and P21 have only animal data despite marketing claims
• Cerebrolysin has some clinical trials but remains unapproved in most Western countries

Regulatory Considerations

In the United States:

• None of these peptides are FDA-approved
• They cannot legally be sold for human consumption
• Products are typically labeled “for research use only”
• Quality and purity are not guaranteed

Why the Uncertainty?

Several factors make nootropic peptide evidence difficult to evaluate:

1. Publication bias — Positive results more likely to be published
2. Small sample sizes — Most studies have few participants
3. Lack of replication — Few independent confirmations
4. Measuring cognition is hard — Subjective outcomes are unreliable
5. Placebo effects — Expectations strongly affect perceived cognition

Important Warnings

• Not approved for any use in the US
• Unregulated products may be contaminated or mislabeled
• Long-term effects are completely unknown
• Drug interactions have not been studied
• Brain effects could be unpredictable

The Bottom Line

While nootropic peptides are popular in biohacking communities, the evidence base is limited. Most claims rely on animal studies or small, poorly-controlled human trials. Anyone considering these compounds should understand they are experimental with unknown long-term risks.

---

This guide is for educational purposes only. Nootropic peptides are not approved for medical use in the United States.